McKesson (MCK) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

MCK Stock Forecast


McKesson (MCK) stock forecast, based on 29 Wall Street analysts, predicts a 12-month average price target of $701.50, with a high of $715.00 and a low of $688.00. This represents a 0.98% increase from the last price of $694.70.

$450 $510 $570 $630 $690 $750 High: $715 Avg: $701.5 Low: $688 Last Closed Price: $694.7

MCK Stock Rating


McKesson stock's rating consensus is Buy, based on 29 Wall Street analysts. The breakdown includes 1 Strong Buy (3.45%), 24 Buy (82.76%), 4 Hold (13.79%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 29 4 24 1 Strong Sell Sell Hold Buy Strong Buy

MCK Price Target Upside V Benchmarks


TypeNameUpside
StockMcKesson0.98%
SectorHealthcare Stocks 33.91%
IndustryMedical Distribution Stocks-1.64%

Price Target Trends


1M3M12M
# Anlaysts--11
Avg Price Target--$632.82
Last Closing Price$694.70$694.70$694.70
Upside/Downside---8.91%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 253103-117
Mar, 253103-117
Feb, 253104--17
Jan, 253104--17
Dec, 243104--17
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 19, 2024Rob DickersonJefferies$715.00$541.1532.13%2.92%
Nov 07, 2024Eric ColdwellRobert W. Baird$688.00$526.5430.66%-0.96%
Sep 25, 2024George HillDeutsche Bank$579.00$479.1620.84%-16.65%
Sep 24, 2024Eric ColdwellRobert W. Baird$531.00$505.005.15%-23.56%
Sep 13, 2024Stephen BaxterWells Fargo$535.00$511.174.66%-22.99%
Sep 06, 2024Michael ChernyLeerink Partners$665.00$514.7529.19%-4.28%
Sep 05, 2024Michael ChernyBank of America Securities$635.00$526.5020.61%-8.59%
Aug 08, 2024Ann HynesMizuho Securities$570.00$617.51-7.69%-17.95%
Jul 09, 2024Eric ColdwellRobert W. Baird$694.00$589.5317.72%-0.10%
Jun 24, 2024David ToungArgus Research$670.00$608.7210.07%-3.56%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Nov 19, 2024JefferiesBuyBuyhold
Oct 01, 2024BarclaysPositivePositivehold
Sep 25, 2024Deutsche BankBuyBuyhold
Sep 24, 2024WedbushNeutraldowngrade
Sep 23, 2024JefferiesHoldHoldhold
Sep 13, 2024Wells FargoEqual-WeightEqual-Weighthold
Sep 06, 2024Leerink PartnersOutperformOutperformhold
Sep 05, 2024Bank of America SecuritiesBuyBuyhold
Aug 26, 2024Cowen & Co.BuyBuyhold
Jul 19, 2024CitigroupBuyBuyhold

Financial Forecast


EPS Forecast

$-30 $-12 $6 $24 $42 $60 Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$-27.02$7.31$25.23$22.54-----
Avg Forecast$17.23$23.89$25.96$27.61$32.69$36.82$41.28$46.94$53.78
High Forecast$17.68$24.51$26.88$27.95$32.97$37.67$43.85$48.61$55.70
Low Forecast$16.74$23.20$25.16$27.47$32.40$35.56$35.30$45.51$52.14
Surprise %-256.82%-69.40%-2.81%-18.36%-----

Revenue Forecast

$200B $270B $340B $410B $480B $550B Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$238.23B$263.97B$276.71B$308.95B-----
Avg Forecast$240.05B$260.88B$275.91B$311.92B$360.18B$396.03B$424.30B$464.80B$517.85B
High Forecast$244.87B$266.13B$283.48B$312.88B$362.60B$412.08B$425.21B$477.55B$532.05B
Low Forecast$234.74B$255.12B$269.43B$309.58B$357.80B$382.12B$423.39B$453.88B$505.68B
Surprise %-0.76%1.18%0.29%-0.95%-----

Net Income Forecast

$-10B $-6B $-2B $2B $6B $10B Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$-4.34B$1.11B$3.56B$3.00B-----
Avg Forecast$-3.74B$1.15B$3.48B$3.00B$4.38B$4.91B$5.31B$6.29B$7.21B
High Forecast$-2.28B$1.39B$3.60B$3.60B$4.42B$5.05B$5.88B$6.52B$7.47B
Low Forecast$-5.20B$919.44M$3.37B$2.39B$4.34B$4.77B$4.73B$6.10B$6.99B
Surprise %15.99%-3.33%2.28%0.13%-----

MCK Forecast FAQ


Is McKesson stock a buy?

McKesson stock has a consensus rating of Buy, based on 29 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 24 Buy, 4 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that McKesson is a favorable investment for most analysts.

What is McKesson's price target?

McKesson's price target, set by 29 Wall Street analysts, averages $701.5 over the next 12 months. The price target range spans from $688 at the low end to $715 at the high end, suggesting a potential 0.98% change from the previous closing price of $694.7.

How does McKesson stock forecast compare to its benchmarks?

McKesson's stock forecast shows a 0.98% upside, underperforming the average forecast for the healthcare stocks sector (33.91%) and outperforming the medical distribution stocks industry (-1.64%).

What is the breakdown of analyst ratings for McKesson over the past three months?

  • April 2025: 17.65% Strong Buy, 58.82% Buy, 17.65% Hold, 0% Sell, 5.88% Strong Sell.
  • March 2025: 17.65% Strong Buy, 58.82% Buy, 17.65% Hold, 0% Sell, 5.88% Strong Sell.
  • February 2025: 17.65% Strong Buy, 58.82% Buy, 23.53% Hold, 0% Sell, 0% Strong Sell.

What is McKesson’s EPS forecast?

McKesson's average annual EPS forecast for its fiscal year ending in March 2025 is $32.69, marking a 45.03% increase from the reported $22.54 in 2024. Estimates for the following years are $36.82 in 2026, $41.28 in 2027, $46.94 in 2028, and $53.78 in 2029.

What is McKesson’s revenue forecast?

McKesson's average annual revenue forecast for its fiscal year ending in March 2025 is $360.18B, reflecting a 16.58% increase from the reported $308.95B in 2024. The forecast for 2026 is $396.03B, followed by $424.3B for 2027, $464.8B for 2028, and $517.85B for 2029.

What is McKesson’s net income forecast?

McKesson's net income forecast for the fiscal year ending in March 2025 stands at $4.38B, representing an 45.98% increase from the reported $3B in 2024. Projections indicate $4.91B in 2026, $5.31B in 2027, $6.29B in 2028, and $7.21B in 2029.